共 50 条
- [3] Defining benefits and risks for SERMs in clinical trials and clinical practice [J]. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 304 - 314
- [5] Commercializing clinical trials - Risks and benefits of the CRO boom [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (14): : 1365 - 1368
- [6] Weighing the benefits and risks in clinical trials and practice - Introduction [J]. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 279 - 279
- [10] Standardization of retinopathy of prematurity clinical examinations in clinical trials: risks, benefits and alternatives [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 36 (01): : 1 - 2